US 11883492
Combination treatment of chemoresistant cancers
granted A61KA61K2039/505A61K2039/54
Quick answer
US patent 11883492 (Combination treatment of chemoresistant cancers) held by The Regents of the University of California expires Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Jan 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K2039/505, A61K2039/54, A61K2039/545, A61K31/337